tiprankstipranks
Oric Pharmaceuticals initiated with an Overweight at Wells Fargo
The Fly

Oric Pharmaceuticals initiated with an Overweight at Wells Fargo

Wells Fargo initiated coverage of Oric Pharmaceuticals (ORIC) with an Overweight rating and $20 price target

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App